"Le CHU de Rennes, sur son site principal de Pontchaillou, prend en charge des pathologies adultes relevant de la médecine et de la chirurgie. Le centre de soins dentaires, le SAMU-SMUR 35, les services d’urgences adultes médico-chirurgicales et cardiologiques y sont également implantés."

During the past decade, CHU de Rennes conducted 865 clinical trials. In the 10-year time frame, 865 clinical trials started and 97 clinical trials were completed, i.e. on average, 11.2% percent of trials that started reached the finish line to date. In the past 5 years, 400 clinical trials started and 67 clinical trials were completed. i.e. 16.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Rennes" #1 sponsor was "Rennes University Hospital" with 288 trials, followed by "Nantes University Hospital" with 95 trials sponsored, "University Hospital, Brest" with 43 trials sponsored, "The Lymphoma Academic Research Organisation" with 35 trials sponsored and "Hoffmann-La Roche" with 35 trials sponsored. Other sponsors include 700 different institutions and companies that sponsored additional 258 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Rennes" #1 collaborator was "Ministry of Health, France" with 30 trials as a collaborator, "Rennes University Hospital" with 15 trials as a collaborator, "Roche Pharma AG" with 13 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 9 trials as a collaborator and "Hospices Civils de Lyon" with 8 trials as a collaborator. Other collaborators include 601 different institutions and companies that were collaborators in the rest 449 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Rennes" are "Multiple Myeloma" (27 trials), "Multiple Sclerosis" (26 trials), "Heart Failure" (18 trials), "Crohn Disease" (13 trials) and "Ulcerative Colitis" (12 trials). Many other conditions were trialed in "CHU de Rennes" in a lesser frequency.

Most popular intervention types in "CHU de Rennes" are "Drug" (477 trials), "Other" (285 trials), "Device" (181 trials), "Procedure" (110 trials) and "Biological" (58 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (90 trials), "Rituximab" (20 trials), "Lenalidomide" (18 trials), "Cyclophosphamide" (14 trials) and "Dexamethasone" (13 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Rennes" are 1105 trials for "All" genders, 46 trials for "Female" genders and 35 trials for "Male" genders.

Currently, there are 395 active trials in "CHU de Rennes". 19 are not yet recruiting, 268 are recruiting, 103 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 591 completed trials in CHU de Rennes, 2 suspended trials, and 92 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Rennes, 47 "Phase 1" clinical trials were conducted, 188 "Phase 2" clinical trials and 269 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 53 trials, and there were also 315 trials that are defined as “Not Applicable".

CHU de Rennes has several departments that took part in Clinical trials: "CHU Pontchaillou - Hématologie Clinique BMT-HC" - 17 trials, "Hopital de Pontchaillou; Service de Pneumologie" - 14 trials, "Hopital de Pontchaillou; Medicine Interne - Hepatologie" - 6 trials, "Département de Chirurgie Viscérale - Hôpital Pontchaillou" - 4 trials, "Department of Cardiology - CHU Pontchaillou" - 4 trials, "CECOS Bretagne Rennes" - 2 trials, "Radiology Department CHU de Rennes" - 2 trials, "CHU de Rennes - service de neurologie" - 2 trials, "Service d'Urologie- Hôpital Pontchaillou" - 2 trials, "Service de Pédiatrie, Hôpital Sud, CHU de Rennes" - 2 trials, "Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou" - 2 trials